Abbott (ABT) Sees a More Significant Dip Than Broader Market: Some Facts to Know

Abbott stock closed down 2.1%, underperforming the S&P 500's 0.25% loss. The stock has declined 7.33% over the past month, significantly lagging the Medical sector. Upcoming earnings are expected to show $1.43 EPS (10% YoY growth) and $12.91B revenue (13.52% increase). Abbott holds a Zacks Rank #3 (Hold) with a Forward P/E of 18.28, trading at a discount to its industry average.